Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyethyleneimine | 5 | 2009 | 63 | 1.320 |
Why?
|
| Bone Morphogenetic Protein 2 | 4 | 2009 | 350 | 0.960 |
Why?
|
| Drug Carriers | 5 | 2020 | 693 | 0.880 |
Why?
|
| Serum Albumin, Bovine | 4 | 2009 | 324 | 0.770 |
Why?
|
| Nanoparticles | 5 | 2020 | 1905 | 0.720 |
Why?
|
| Drug Delivery Systems | 5 | 2020 | 2218 | 0.660 |
Why?
|
| Diphosphonates | 4 | 2007 | 624 | 0.650 |
Why?
|
| Osteogenesis | 2 | 2009 | 1299 | 0.420 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2009 | 319 | 0.360 |
Why?
|
| Polyethylene Glycols | 2 | 2014 | 1181 | 0.320 |
Why?
|
| Polylysine | 2 | 2008 | 133 | 0.310 |
Why?
|
| Nanocapsules | 1 | 2008 | 91 | 0.300 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2008 | 282 | 0.300 |
Why?
|
| Serum Albumin | 1 | 2009 | 676 | 0.280 |
Why?
|
| Durapatite | 1 | 2007 | 161 | 0.270 |
Why?
|
| Bone Diseases | 2 | 2006 | 416 | 0.270 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 222 | 0.250 |
Why?
|
| Disulfides | 2 | 2005 | 457 | 0.240 |
Why?
|
| Metal Nanoparticles | 1 | 2008 | 405 | 0.230 |
Why?
|
| Nanotechnology | 1 | 2009 | 710 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1676 | 0.200 |
Why?
|
| Drug Design | 1 | 2006 | 1078 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2425 | 0.190 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 773 | 0.170 |
Why?
|
| Inflammation | 1 | 2015 | 10634 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2020 | 1962 | 0.130 |
Why?
|
| Cattle | 3 | 2009 | 3922 | 0.120 |
Why?
|
| Heparin | 1 | 2020 | 1637 | 0.110 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 406 | 0.110 |
Why?
|
| Intestines | 1 | 2020 | 1924 | 0.100 |
Why?
|
| Boronic Acids | 1 | 2014 | 965 | 0.090 |
Why?
|
| Metabolic Clearance Rate | 1 | 2009 | 379 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6386 | 0.090 |
Why?
|
| Animals | 10 | 2020 | 168788 | 0.080 |
Why?
|
| Rats | 4 | 2009 | 24273 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2014 | 1132 | 0.080 |
Why?
|
| Pyrazines | 1 | 2014 | 1231 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2015 | 1948 | 0.080 |
Why?
|
| Biocompatible Materials | 2 | 2007 | 1736 | 0.080 |
Why?
|
| Biological Availability | 1 | 2008 | 396 | 0.080 |
Why?
|
| Sulfhydryl Compounds | 2 | 2005 | 297 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1772 | 0.070 |
Why?
|
| Colitis | 1 | 2015 | 1170 | 0.070 |
Why?
|
| Implants, Experimental | 1 | 2007 | 104 | 0.070 |
Why?
|
| Bone Matrix | 1 | 2007 | 118 | 0.070 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2005 | 21 | 0.070 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2005 | 68 | 0.070 |
Why?
|
| Succinimides | 1 | 2005 | 79 | 0.070 |
Why?
|
| Hydroxyapatites | 1 | 2005 | 75 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2009 | 2335 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2009 | 2007 | 0.060 |
Why?
|
| Cell Line | 2 | 2009 | 15999 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 3036 | 0.060 |
Why?
|
| Cysteine | 2 | 2005 | 874 | 0.060 |
Why?
|
| Biopsy | 1 | 2015 | 6757 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 626 | 0.060 |
Why?
|
| Glutathione | 1 | 2005 | 588 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 694 | 0.050 |
Why?
|
| Homocysteine | 1 | 2005 | 647 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2014 | 3584 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1907 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2525 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 1387 | 0.050 |
Why?
|
| Macrophages | 1 | 2015 | 5657 | 0.050 |
Why?
|
| Kinetics | 1 | 2008 | 6474 | 0.050 |
Why?
|
| Regeneration | 1 | 2009 | 1485 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2006 | 807 | 0.050 |
Why?
|
| Mice | 3 | 2020 | 81178 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8302 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2007 | 1880 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2014 | 5180 | 0.030 |
Why?
|
| Alendronate | 1 | 2014 | 171 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10949 | 0.030 |
Why?
|
| Humans | 7 | 2020 | 744220 | 0.030 |
Why?
|
| Proteins | 1 | 2006 | 6101 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 13668 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2085 | 0.020 |
Why?
|
| Acetone | 1 | 2008 | 43 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 1275 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 63119 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 7179 | 0.020 |
Why?
|
| Drug Stability | 1 | 2008 | 291 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3689 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3557 | 0.020 |
Why?
|
| Particle Size | 1 | 2008 | 1642 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40063 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16687 | 0.010 |
Why?
|
| Female | 1 | 2009 | 380197 | 0.010 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_